DEFERIPRON

Deferoxamine mesylate is a parenteral iron chelator that binds ferric iron and promotes renal and biliary excretion. It is used in acute iron poisoning and chronic overload. Benefits include rapid reduction of free iron. Side effects include injection‑site reactions, visual and auditory disturbances, and hypotension with rapid infusion.

SKU: 8c5c15167a11 Category: Tag:

Product Description


Mechanism of Action

Deferiprone is a bidentate iron‑chelating agent that binds Fe³⁺ with high affinity, forming a 3:1 drug‑to‑iron complex. It reduces toxic iron accumulation in tissues, prevents Fenton‑reaction‑driven oxidative damage, and modulates iron‑regulatory pathways at the cellular level.

Benefits and Advantages

Used in iron‑overload models, chelation‑therapy research, oxidative‑stress assays, iron‑transport studies and mitochondrial‑damage modelling.

Side Effects and Risks

Risks include agranulocytosis, neutropenia, arthralgia, gastrointestinal discomfort, zinc depletion and hepatic dysfunction. Handle with hematologic‑risk controls.

Datasheet


Molecular Formula

C7H9NO2

Molecular Weight

139.15 g/mol

CAS Number

30652-11-0

Storage Condition

Store at 20 deg to 25 °C (68 deg to 77 °F); excursions permitted to 15 deg to 30 °C (59 deg to 86 °F).

Solubility

Maximum water solubility of 16€“18 g/L at 24°

Purity

Purity information is available upon request (COA).

Synonym

deferiprone; 30652-11-0; 3-Hydroxy-1,2-dimethyl-4(1H)-pyridone; Ferriprox; 3-hydroxy-1,2-dimethylpyridin-4(1H)-one

IUPAC/Chemical Name

3-hydroxy-1,2-dimethylpyridin-4-one

InChl Key

TZXKOCQBRNJULO-UHFFFAOYSA-N

InChl Code

InChI=1S/C7H9NO2/c1-5-7(10)6(9)3-4-8(5)2/h3-4,10H,1-2H3

References

https://pubchem.ncbi.nlm.nih.gov/compound/2972;

3D Conformer.

(Click, turn or enlarge)

Download our GMP API Product List.

MedicaPharma is an EU-based supplier of GMP-certified APIs that serves leading healthcare institutions and research organizations.
Click here to download our full API product list.

Download